Show simple item record

Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States

dc.contributor.authorWaits, Seth A.en_US
dc.contributor.authorWojcik, Brandon M.en_US
dc.contributor.authorCai, Shijieen_US
dc.contributor.authorMathur, Amit K.en_US
dc.contributor.authorEnglesbe, Michael J.en_US
dc.date.accessioned2011-11-10T15:36:03Z
dc.date.available2012-11-02T18:56:46Zen_US
dc.date.issued2011-09en_US
dc.identifier.citationWaits, Seth A.; Wojcik, Brandon M.; Cai, Shijie; Mathur, Amit K.; Englesbe, Michael J. (2011). "Portal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United States ." Liver Transplantation 17(9): 1066-1072. <http://hdl.handle.net/2027.42/87010>en_US
dc.identifier.issn1527-6465en_US
dc.identifier.issn1527-6473en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/87010
dc.description.abstractThe effect of occlusive portal vein thrombosis (PVT) on the mortality of pediatric liver transplant candidates and recipients is poorly defined. Using standard multivariate techniques, we studied the relationship between PVT and waiting‐list and posttransplant survival rates with data from the Scientific Registry of Transplant Recipients (September 2001 to December 2007). In all, 5087 liver transplant candidates and 3630 liver transplant recipients were evaluated during the period. PVT was found in 1.4% of the liver transplant candidates (n = 70) and in 3.7% of the liver transplant recipients (n = 136). PVT was not associated with increased wait‐list mortality [hazard ratio (HR) = 1.1, 95% confidence interval (CI) = 0.5‐2.4, P = 0.77]. Conversely, PVT patients had a significantly lower unadjusted survival rate in the posttransplant period ( P = 0.01). PVT was independently associated with increased posttransplant mortality in multivariate models (30‐day survival: HR = 2.9, 95% CI = 1.6‐5.3, P = 0.001; overall survival: HR = 1.7, 95% CI = 1.1‐2.4, P = 0.01). The presence of PVT in pediatric liver candidates was not associated with increased wait‐list mortality but was clearly associated with posttransplant mortality, especially in the immediate postoperative period. Liver Transpl 17:1066–1072, 2011. © 2011 AASLD.en_US
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.titlePortal vein thrombosis and outcomes for pediatric liver transplant candidates and recipients in the United Statesen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelSurgery and Anesthesiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartments of Surgery, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationumDepartment of Biostatistics, University of Michigan, Ann Arbor, MIen_US
dc.contributor.affiliationumUniversity of Michigan Health System, 2926 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109‐0331en_US
dc.identifier.pmid21744467en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/87010/1/22371_ftp.pdf
dc.identifier.doi10.1002/lt.22371en_US
dc.identifier.sourceLiver Transplantationen_US
dc.identifier.citedreferenceAmitrano L, Guardascione MA, Brancaccio V, Margaglione M, Manguso F, Iannaccone L, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736 – 741.en_US
dc.identifier.citedreferenceDenninger MH, Chaït Y, Casadevall N, Hillaire S, Guillin MC, Bezeaud A, et al. Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology 2000; 31: 587 – 591.en_US
dc.identifier.citedreferenceSogaard KK, Astrup LB, Vilstrup H, Gronbaek H. Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol 2007; 7: 34.en_US
dc.identifier.citedreferenceMolmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002; 235: 292 – 296.en_US
dc.identifier.citedreferenceJanssen HL, Wijnhoud A, Haagsma EB, van Uum SH, van Nieuwkerk CM, Adang RP, et al. Extrahepatic portal vein thrombosis: aetiology and determinants of survival. Gut 2001; 49: 720 – 724.en_US
dc.identifier.citedreferenceGoulding C, Uttenthal B, Foroni L, Duke V, Traore A, Kottaridis P, et al. The JAK2(V617F) tyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis. Int J Lab Hematol 2008; 30: 415 – 419.en_US
dc.identifier.citedreferenceOgren M, Bergqvist D, Björck M, Acosta S, Eriksson H, Sternby NH. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23,796 consecutive autopsies. World J Gastroenterol 2006; 12: 2115 – 2119.en_US
dc.identifier.citedreferenceOrloff MJ, Orloff MS, Orloff SL, Girard B. Portal vein thrombosis in cirrhosis with variceal hemorrhage. J Gastrointest Surg 1997; 1: 123 – 130.en_US
dc.identifier.citedreferenceEgawa H, Tanaka K, Kasahara M, Takada Y, Oike F, Ogawa K, et al. Single center experience of 39 patients with preoperative portal vein thrombosis among 404 adult living donor liver transplantations. Liver Transpl 2006; 12: 1512 – 1518.en_US
dc.identifier.citedreferenceGerbes AL. The patient with refractory ascites. Best Pract Res Clin Gastroenterol 2007; 21: 551 – 560.en_US
dc.identifier.citedreferenceSchettino GC, Fagundes ED, Roquete ML, Ferreira AR, Penna FJ. Portal vein thrombosis in children and adolescents. J Pediatr (Rio J) 2006; 82: 171 – 178.en_US
dc.identifier.citedreferenceChardot C, Herrera JM, Debray D, Branchereau S, De Dreuzy O, Devictor D, et al. Portal vein complications after liver transplantation for biliary atresia. Liver Transpl Surg 1997; 3: 351 – 358.en_US
dc.identifier.citedreferenceAl‐Holou S, Mathur AK, Ranney D, Kubus J, Englesbe MJ. Survival among children with portal vein thrombosis and end‐stage liver disease. Pediatr Transplant 2010; 14: 132 – 137.en_US
dc.identifier.citedreferenceEnglesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010; 16: 999 – 1005.en_US
dc.identifier.citedreferenceRana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008; 8: 2537 – 2546.en_US
dc.identifier.citedreferenceEnglesbe MJ, Kubus J, Muhammad W, Sonnenday CJ, Welling T, Punch JD, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010; 16: 83 – 90.en_US
dc.identifier.citedreferenceParikh S, Shah R, Kapoor P. Portal vein thrombosis. Am J Med 2010; 123: 111 – 119.en_US
dc.identifier.citedreferenceRavindra KV, Guthrie JA, Woodley H, Davison S, McClean P, Prasad KR, Stringer MD. Preoperative vascular imaging in pediatric liver transplantation. J Pediatr Surg 2005; 40: 643 – 647.en_US
dc.identifier.citedreferenceYu CY, Concejero AM, Huang TL, Chen TY, Tsang LL, Wang CC, et al. Preoperative vascular evaluation in living donor liver transplantation for biliary atresia. Transplant Proc 2008; 40: 2478 – 2480.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.